Manifold Bio
Tissue-targeted medicines, designed in vivo.
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Explore similar companies to Manifold Bio
Science
A brighter tomorrow enabled by neural engineering.
Biotech · Series C · Onsite · Based in Alameda
Loyal
Extending the lifespan of dogs.
Biotech · Series C · Remote · Based in San Francisco
Kingdom Supercultures
Natural functional ingredients that actually work.
Biotech · Series A · Onsite · Based in New York
CuspAI
Frontier AI for breakthrough materials.
Biotech · Series A · Remote · Based in London
Cortical Labs
Lab-grown neurons with silicon chips.
Biotech · Seed · Remote · Based in Melbourne
Convoke
AI-native OS for drug development.
Biotech · Seed · Onsite · Based in San Francisco
Converge Bio
Accelerating therapeutic breakthroughs with AI.
Biotech · Series A · Remote · Based in Tel Aviv
Mantis Biotech
Infrastructure for human-in-computer models.
Biotech · Seed · Onsite · Based in New York
Bindwell
Building better pesticides with AI.
Biotech · Seed · Onsite · Based in San Francisco
Industries
Investors
Cities